Can I Start on 5mg Tirzepatide, or Does the Schedule Have to Begin at 2.5mg?

Step 1: Why the schedule starts at 2.5mg, not 5mg

The UK-licensed dose schedule for tirzepatide runs through six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, each pen lasting four weeks. The first pen (the 2.5mg) is a tolerability dose. Its job is not to produce significant weight loss; it is to let your digestive system adjust to the way tirzepatide slows gastric emptying before the dose goes any higher.

Tirzepatide activates two gut-hormone receptors simultaneously (GIP and GLP-1), and that dual action is part of why it produces meaningful results in trials. It is also why the early weeks can bring nausea, loose stools, or a heavy feeling after eating. Starting lower reduces the chance that those effects hit hard enough to push someone off treatment altogether. The full Mounjaro overview explains the mechanism and what to expect across the schedule.

Bypassing 2.5mg and beginning at 5mg would expose someone to a higher level of GI stimulation from day one, without that acclimatisation window. For most people, that trade-off does not make clinical sense. If you are wondering whether starting Mounjaro at 5mg is something a prescriber would agree to, the answer depends on your clinical history and is not a decision you make unilaterally. The SmPC published on the electronic Medicines Compendium (eMC) sets out the schedule clearly, and a prescriber is bound by that unless there is documented clinical reason to deviate.

Step 2: The narrow situations where a prescriber might consider 5mg as an opening dose

There are scenarios where a clinician could make a case for beginning above 2.5mg, for example, someone transferring from another GLP-1 medicine who has already demonstrated tolerance of this class of drug, or someone with documented prior exposure to tirzepatide at a higher dose who is restarting after a planned break. These are edge cases.

Even in transfer situations, the prescriber needs evidence: a record of the previous treatment, the dose reached, and how the transition was managed. At nume, patients moving from another service provide that evidence as part of the intake process, and the prescriber decides the appropriate starting point based on it. Nobody self-selects their opening dose.

If you are starting tirzepatide for the first time, with no GLP-1 history, beginning at 5mg is not something a responsible prescriber would ordinarily approve. The licensed schedule exists for a reason, and a prescriber deviating from it without clinical justification would be stepping outside their regulatory obligations. For more on what the 5mg dose involves once you reach it, the tirzepatide 5mg page covers what changes at that stage.

Step 3: What happens if 5mg feels too fast when you get there

The flip side of this question is also worth addressing: what if moving up to 5mg after four weeks is too much? Staying at 2.5mg beyond the standard four-week window is legitimate if your prescriber agrees the timing is right for your body. There is no rule that forces a dose increase on a fixed calendar if you are still managing significant side effects.

People sometimes assume that slower titration means treatment is not working. It does not. Clinical trials for tirzepatide (including SURMOUNT-1, which involved over 2,500 adults and was published in the New England Journal of Medicine) used the licensed schedule as written, and even at that pace produced average weight reductions of around 20% at the highest dose. The schedule is calibrated to get people to an effective dose without losing them to side effects along the way.

If you are weighing up whether to stay at 2.5mg longer, this page on staying at 2.5mg tirzepatide covers what the guidance says and when that conversation is worth having with your prescriber. Your prescriber (not a general timetable) makes that call at each repeat review.

What this means for your consultation

The short answer to whether you can start on 5mg tirzepatide is: not typically, and not without clinical justification. The licensed starting point is 2.5mg. A prescriber can make an exception in the right circumstances, but that is their decision to make with your full medical history in front of them, not a preference you select at checkout.

At nume, every prescription is written by a GPhC-registered Independent Prescriber who reviews your consultation personally, the same day. Dose decisions are part of that review. If you have a specific clinical history that might affect where you start, that conversation happens before anything is dispensed. The NHS tirzepatide page sets out the standard schedule and what to discuss with your healthcare team if you have concerns about it.

For context on the private cost of treatment across the dose range, the Mounjaro cost page gives a factual overview of how pricing typically works. And if you are still working out whether tirzepatide is the right medicine for your situation, the weight-loss treatments overview covers the licensed options side by side. When you are ready, starting your free consultation is the next step, a prescriber will take it from there.